Christina Izzo

Patient portals are giving patients new ways to access their healthcare information and communicate with members of their healthcare team.

Jacquelyn Lauria said she never thought she'd become an oncology nurse, but looking back, it's easy to see the writing on the wall.

Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.

New research reported at the AACR Annual Meeting has found that decreasing the number of hours spent eating each day and increasing the number of hours spent fasting overnight may reduce a woman's risk of developing breast cancer.

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

A new study has found that obesity is associated with an increased risk for prostate cancer in African American men, a risk that grows by nearly four times as an individual's body-mass index (BMI) increases.

A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management, and healthy eating.

A new study has found that patients with lower vitamin D levels prior to treatment for follicular lymphoma are more likely to die or relapse from the disease earlier than patients with adequate vitamin D levels in their blood.

Many women who are diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. However, a large amount of those concerns are not being addressed, according to a new study.

The link between diabetes and late-stage breast cancer is strong, according to a new study.

A new study has found that although the number of childhood cancer survivors is increasing, the majority of those to survive 5 or more years beyond diagnosis have at least one chronic health condition.

The FDA has approved deferasirox (Jadenu) for the treatment of chronic iron overload, a condition that can affect patients with myelodysplastic syndromes (MDS), sickle cell disease, and thalassemia.

A new study has found that current smoking and heavy alcohol consumption appear to be risk factors for prolonged use of a gastrostomy tube (GT, feeding tube) in patients with head and neck cancer who are undergoing radiotherapy or chemoradiotherapy.

A new study has shown that men with a high fitness level in midlife are not only at a lower risk of developing lung and colorectal cancer, they're also at a lower risk of dying from cancer if they're diagnosed later in life.

A new study has found that a psychosocial telephone counseling intervention helps improve mood and quality of life in cervical cancer survivors.

Results of a follow up study have shown that when women were taught stress management techniques early in their breast cancer treatment, their mood and quality of life continued to improve up to 15 years later.

Recent advancements in the treatment of ovarian cancer, including surgical techniques, the approvals of bevacizumab and olaparib, and intraperitoneal chemotherapy (IP), have led the National Comprehensive Cancer Network to make changes to their clinical practice guidelines in its 20th annual edition.

A new study has found that African American patients with cancer feel and describe depression differently than their Caucasian counterparts.

Based on results from a new study, researchers now have a better understanding about the mechanisms behind the link between aspirin, NSAIDs, and colorectal cancer prevention.

A new study hopes to gain some clarity on what causes some breast cancer patients to feel "foggy" when receiving chemotherapy.

Having a family history of prostate cancer among first-degree relatives may also increase a women's risk of developing breast cancer, according to a new study.

The FDA has approved nivolumab (Opdivo) for the treatment of patients with advanced squamous non–small cell lung cancer (NSCLC) who have progressed on or after platinum-based chemotherapy.

The FDA's approval of panobinostat (Farydak) for multiple myeloma, the first histone deacetylase (HDAC) inhibitor to be approved in this space, provides a new option and new hope for patients with this disease, Walter M. Capone, President and Chief Executive Officer of the Multiple Myeloma Research Foundation, said.

Results of a new study may help boost lung cancer clinical trial enrollment.

Pain in patients with breast cancer who have had surgery or who have late-stage disease is common, and managing it effectively can be difficult.

Two new studies highlight the need for cancer survivors and their families to get guidance on healthy lifestyle changes and when the best time might be to integrate them.

A new analysis has shown that taking hormone replacement therapy to alleviate symptoms associated with menopause significantly increases the risk of developing the two most common types of ovarian cancer, even if the therapy is only taken for a few years.

Although some physicians may blame patient demands for the increase in medical costs, a new study has shown that cancer patients rarely push their doctor to run unnecessary tests and treatments.

When a cancer diagnosis occurs during this time, physicians and nurses must take special care to discuss certain issues that they may not discuss with pediatric or adult patients.

The big difference in progression-free survival seen in pivotal trial data propelled palbociclib to its accelerated FDA approval for the treatment of metastatic breast cancer, bringing with it the potential for the drug to quickly become adapted as the new standard of care, Brian Wojciechowski, MD, said.